AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
158 hedge funds and large institutions have $830M invested in Aerie Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 61 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less call options, than puts
Call options by funds: $3.8M | Put options by funds: $5.06M
Holders
158
Holding in Top 10
–
Calls
$3.8M
Puts
$5.06M
Top Buyers
| 1 | +$38.5M | |
| 2 | +$14.8M | |
| 3 | +$9.46M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$8.59M |
| 5 |
ACM
Atika Capital Management
New York
|
+$8.58M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$8.14M | |
| 3 | -$6.14M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$6.11M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6.07M |